Works matching IS 10781552 AND DT 2011 AND VI 17 AND IP 4

Results: 26

Potential for drug–drug interactions in treating cancer-related nausea and distress.

Published in:

2011

By:

Saylor, Matthew S;
Smetana, Ronald F

Publication type:

Journal Article

Treatment of concurrent metastatic renal cell carcinoma and chronic myelogenous leukemia – easier said than done? A case report.

Published in:

2011

By:

Al-Najjar, Fouad;
Jarkowski, Anthony

Publication type:

Journal Article

Reviewers list.

Published in:: Journal of Oncology Pharmacy Practice, 2011, v. 17, n. 4, p. 456, doi. 10.1177/1078155211429767
Publication type:: Article

International Medication Safety Self Assessment for Oncology Practice.

Published in:

Journal of Oncology Pharmacy Practice, 2011, v. 17, n. 4, p. 303, doi. 10.1177/1078155211426761

By:

Johnson, Philip E;
Chambers, Carole R;
Vaida, Allen J;
Shastay, Ann;
Greenall, Julie

Publication type:

Article

Impact of clinical pharmacy services on patients in an outpatient chemotherapy academic clinic.

Published in:

Journal of Oncology Pharmacy Practice, 2011, v. 17, n. 4, p. 387, doi. 10.1177/1078155210389217

By:

McKee, Megan;
Frei, Bradi L;
Garcia, Anita;
Fike, David;
Soefje, Scott A

Publication type:

Article

Is there a benefit to having a clinical oncology pharmacist on staff at a community oncology clinic?

Published in:

Journal of Oncology Pharmacy Practice, 2011, v. 17, n. 4, p. 425, doi. 10.1177/1078155210389216

By:

Ruder, Aimee Danette;
Smith, Douglas Lamont;
Madsen, Michael Thornton;
Kass, Frederic Henry

Publication type:

Article

Rituximab tolerability when given before or after CHOP.

Published in:

Journal of Oncology Pharmacy Practice, 2011, v. 17, n. 4, p. 381, doi. 10.1177/1078155210386989

By:

Hannawa, Idan S;
Bestul, Daniel J

Publication type:

Article

Stability of unused reconstituted bortezomib in original manufacturer vials.

Published in:

Journal of Oncology Pharmacy Practice, 2011, v. 17, n. 4, p. 400, doi. 10.1177/1078155210386268

By:

Vanderloo, Joshua P;
Pomplun, Marcia L;
Vermeulen, Lee C;
Kolesar, Jill M

Publication type:

Article

Key components of intravenous chemotherapy labeling: A systematic review and practice guideline.

Published in:

Journal of Oncology Pharmacy Practice, 2011, v. 17, n. 4, p. 409, doi. 10.1177/1078155210385160

By:

Trudeau, Maureen;
Green, Esther;
Cosby, Roxanne;
Charbonneau, Flay;
Easty, Tony;
Ko, Yooj;
Marchand, Patti;
David, U;
Berger, Nadia;
Hertz, Sherrie

Publication type:

Article

Evaluation of methylene blue, thiamine, and/or albumin in the prevention of ifosfamide-related neurotoxicity.

Published in:

Journal of Oncology Pharmacy Practice, 2011, v. 17, n. 4, p. 372, doi. 10.1177/1078155210385159

By:

Richards, Ashley;
Marshall, Helen;
McQuary, Amy

Publication type:

Article

Conditions causing gemcitabine crystallization.

Published in:

Journal of Oncology Pharmacy Practice, 2011, v. 17, n. 4, p. 395, doi. 10.1177/1078155210385033

By:

Manners, Susan;
Galettis, Peter;
Souza, Paul de

Publication type:

Article

Isolated mucinous adrenal metastasis in a breast cancer patient.

Published in:

Journal of Oncology Pharmacy Practice, 2011, v. 17, n. 4, p. 444, doi. 10.1177/1078155210384893

By:

Demirci, Umut;
Buyukberber, Suleyman;
Cakir, Tansel;
Poyraz, Aylar;
Baykara, Meltem;
Karakus, Esra;
Tufan, Gulnihal;
Benekli, Mustafa;
Coskun, Ugur

Publication type:

Article

Pregnancy a short time after multimodal therapy for bilateral breast cancer: A case report and review of literature.

Published in:

Journal of Oncology Pharmacy Practice, 2011, v. 17, n. 4, p. 440, doi. 10.1177/1078155210384755

By:

Koca, Timur;
Akgun, Zuleyha;
Yucel, Serap Baskaya;
Dag, Nihal Zerman;
Teomete, Mehmet

Publication type:

Article

Incidence of myelodysplastic syndromes in patients receiving concurrent myelosuppressive chemotherapy and pegfilgrastim.

Published in:

Journal of Oncology Pharmacy Practice, 2011, v. 17, n. 4, p. 366, doi. 10.1177/1078155210384445

By:

Covert, Wendy M;
Murillo, Jose R;
Cox, James E

Publication type:

Article

Etoposide in continuous infusion: Practical recommendations for pediatric protocols.

Published in:

2011

By:

Bauters, Tiene;
Vandenbroucke, Johan;
Moerloose, Barbara De;
Porre, Johan De;
Benoit, Yves;
Robays, Hugo

Publication type:

Opinion

Potential for drug–drug interactions in treating cancer-related nausea and distress.

Published in:

Journal of Oncology Pharmacy Practice, 2011, v. 17, n. 4, p. 403, doi. 10.1177/1078155210384301

By:

Saylor, Matthew S;
Smetana, Ronald F

Publication type:

Article

The effect of monotherapy and combined therapy with NSC-631570 (Ukrain) on growth of low- and high-metastasizing B16 melanoma in mice.

Published in:

Journal of Oncology Pharmacy Practice, 2011, v. 17, n. 4, p. 339, doi. 10.1177/1078155210382470

By:

Skivka, LM;
Susak, YaM;
Trompak, OO;
Kudryavets, YuI;
Bezdeneznikh, N;
Semesiuk, N;
Lykhova, O

Publication type:

Article

Transfusions increase with nationally driven reimbursement changes of erythropoiesis stimulating agents for chemotherapy-induced anemia.

Published in:

Journal of Oncology Pharmacy Practice, 2011, v. 17, n. 4, p. 360, doi. 10.1177/1078155210382318

By:

Yu, Janny ManYan;
Shord, Stacy S;
Cuellar, Sandra

Publication type:

Article

Blood pressure control in patients receiving bevacizumab in an outpatient cancer center.

Published in:

Journal of Oncology Pharmacy Practice, 2011, v. 17, n. 4, p. 333, doi. 10.1177/1078155210382150

By:

Bottiglieri, Sal;
Muluneh, Benyam;
Sutphin, Stephanie;
Iacovelli, Lew;
Adams, Val

Publication type:

Article

Treatment of concurrent metastatic renal cell carcinoma and chronic myelogenous leukemia – easier said than done? A case report.

Published in:

Journal of Oncology Pharmacy Practice, 2011, v. 17, n. 4, p. 436, doi. 10.1177/1078155210382060

By:

Al-Najjar, Fouad;
Jarkowski, Anthony

Publication type:

Article

Occupational exposure to antineoplastic drugs in seven Italian hospitals: The effect of quality assurance and adherence to guidelines.

Published in:

Journal of Oncology Pharmacy Practice, 2011, v. 17, n. 4, p. 320, doi. 10.1177/1078155210381931

By:

Turci, Roberta;
Minoia, Claudio;
Sottani, Cristina;
Coghi, Raffaella;
Severi, Paolo;
Castriotta, Cecilia;
Del Bianco, Massimo;
Imbriani, Marcello

Publication type:

Article

Should the concomitant use of erlotinib and acid-reducing agents be avoided? The drug interaction between erlotinib and acid-reducing agents.

Published in:

Journal of Oncology Pharmacy Practice, 2011, v. 17, n. 4, p. 448, doi. 10.1177/1078155210381794

By:

Duong, Silvia;
Leung, Mova

Publication type:

Article

Oxaliplatin-induced acute thrombocytopenia.

Published in:

Journal of Oncology Pharmacy Practice, 2011, v. 17, n. 4, p. 433, doi. 10.1177/1078155210381287

By:

Mason, Jessica M;
Rees, Gareth JG

Publication type:

Article

Incidence and risk factors of clinically significant chemotherapy-induced thrombocytopenia in patients with solid tumors*.

Published in:

Journal of Oncology Pharmacy Practice, 2011, v. 17, n. 4, p. 312, doi. 10.1177/1078155210380293

By:

Hitron, Anna;
Steinke, Doug;
Sutphin, Stephanie;
Lawson, Amber;
Talbert, Jeff;
Adams, Val

Publication type:

Article

Impact of erythropoiesis-stimulating agent prescribing at an Asian cancer center, after release of safety advisories.

Published in:

Journal of Oncology Pharmacy Practice, 2011, v. 17, n. 4, p. 350, doi. 10.1177/1078155210378058

By:

Chan, QingRu;
Chan, Alexandre

Publication type:

Article

Treatment adherence of cancer patients to orally administered chemotherapy: Insights from a Greek study using a self-reported questionnaire.

Published in:

Journal of Oncology Pharmacy Practice, 2011, v. 17, n. 4, p. 304, doi. 10.1177/1078155210380292

By:

Saratsiotou, Ioanna;
Kordoni, Maria;
Bakogiannis, Charalampos;
Livadarou, Eleftheria;
Skarlos, Dimosthenis;
Kosmidis, Paris A;
Razis, Evangelia

Publication type:

Article